Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy

NCT00159731 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy

Interventions

DRUG: Pregabalin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.